Chronic cough, defined as a cough lasting more than eight weeks, is a common yet challenging condition encountered in primary care and respiratory clinics. It often presents a diagnostic puzzle, with patients undergoing numerous investigations to identify its etiology. This article offers a comprehensive approach to diagnosing and treating chronic cough, aiming to enhance patient care and clinical outcomes.
Chronic cough may result from a wide range of conditions. The most common causes include gastroesophageal reflux disease (GERD), postnasal drip syndrome, and asthma. However, less common causes such as lung cancer, sarcoidosis, and foreign body aspiration should also be considered. A thorough history and physical examination, along with appropriate diagnostic testing, are crucial in pinpointing the cause.
Initial evaluation should focus on identifying common causes. If these are ruled out, consider less common causes and referral to a respiratory specialist. Chest X-ray, spirometry, and upper airway endoscopy can be useful initial investigations. In refractory cases, high-resolution computed tomography (HRCT) and bronchoscopy may be warranted.
Treatment should be targeted towards the underlying cause. For GERD-related cough, proton pump inhibitors may be beneficial. Inhaled corticosteroids are often effective for asthma-related cough, while antihistamines and decongestants can alleviate postnasal drip syndrome. In cases where no cause is found, empirical treatment with cough suppressants or neuromodulators may be considered.
Chronic cough is a complex condition requiring a systematic and comprehensive approach for effective management. Identifying the underlying cause is paramount and often requires a combination of clinical assessment and diagnostic testing. Tailored treatment strategies can significantly improve patient outcomes, reducing morbidity and improving quality of life. Continued research and clinical discussion are needed to further refine our approach to this challenging clinical entity.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation